Real World Asparaginase Therapy Toxicity
ConditionDrug Toxicity
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorSt. Jude Children's Research Hospital
About this trial
This research study is being done to learn more about the short term and long term side effects of treatment with asparaginase drugs, which are commonly used in acute lymphoblastic leukemia (ALL) or acute lymphoblastic lymphoma (LLy) therapy.
Eligibility criteria
Qualifiers
Diagnosis of acute lymphoblastic leukemia, lymphoblastic lymphoma, or mixed phenotype acute leukemia
Enrolled on INITIALL and no more than 10 days after initiation of post-INITIALL therapy
Standard of Care (SOC)/Non Protocol Treatment Plan (NPTP) as per Total therapy or
SJALL23T and not scheduled to receive venetoclax
Disqualifiers
Inability or unwillingness of research participant or legal guardian/representative to give written informed consent.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
200 Participants
are grouped into 2 trial groupsSponsors and collaborators
Source ClinicalTrials.gov